Poly (ADP-ribose) polymerase-1 (PARP-1) − 410C/T polymorphism in Sicilian patients with Parkinson's disease

Journal of the Neurological Sciences

Volumn 363, Issue , 2016, Pages 95-96

  Salluzzo, Maria Grazia ^a   Cosentino, Filomena I ^a   Romano, Carmelo ^a   Scillato, Francesco ^a   Morale, Maria Concetta ^a   Rando, Rosanna Galati ^a   Elia, Federica ^a   Spada, Rosario S ^a   Bosco, Paolo ^a   Salemi, Michele ^a  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

genetic markers; Parkinson's disease; PARP 1 gene; PARP 1 410 C T polymorphism

Indexed keywords

GENOMIC DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PARP1 PROTEIN, HUMAN;

AGED; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA ISOLATION; FEMALE; GENE; GENE EXPRESSION; GENETIC ANALYZER; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFORMED CONSENT; ITALY; LETTER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PARKINSON DISEASE; PARP 1 GENE; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; SICILY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; HUMANS; MALE; PARKINSON DISEASE; POLY (ADP-RIBOSE) POLYMERASE-1; POLYMORPHISM, GENETIC; SICILY;

EID: 84979083733     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2016.02.039     Document Type: Letter

References (9)

1. [1] Alves, G., Forsaa, E.B., Pedersen, K.F., Dreetz Gjerstad, M., Larsen, J.P., Epidemiology of Parkinson's disease. J. Neurol. 255 (2008), 18–32.
2. [2] Ataie, A., Ataee, R., Mansoury, Z., Aghajanpour, M., Homocysteine intracerebroventricular injection induces apoptosis in the substantia nigra cells and Parkinson's disease like behavior in rats. Int. J. Mol. Cell. Med. 2 (2013), 80–85.
3. [3] Mochizuki, H., Goto, K., Mori, H., Mizuno, Y., Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137 (1996), 120–123.
4. [4] Koh, D.W., Dawson, T.M., Dawson, V.L., Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol. Res. 52 (2005), 5–14.
5. [5] Ossovskaya, V., Koo, I.C., Kaldjian, E.P., Alvares, C., Sherman, B.M., Up-regulation of poly(ADP-ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types. Genes Cancer 8 (2010), 812–821.
6. [6] Chiarugi, A., Moskowitz, M.A., Poly(ADP-ribose) polymerase-1 activity promotes NF-kappa driven transcription and microglial activation: implication for neurodegenerative disorders. J. Neurochem., 85, 2003, 306.
7. [7] Infante, J., Sánchez-Juan, P., Mateo, I., Rodríguez-Rodríguez, E., Sánchez-Quintana, C., Llorca, J., et al. Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease. J. Neurol. Sci. 256 (2007), 68–70.
8. [8] Gibb, W.R., Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad. Med. J., 64, 1988, 345.
9. [9] Salemi, M., Salluzzo, M.G., Calogero, A.E., Raffaele, F., Bosco, P., 2014 association study of COX-2 (PTGS2) -765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer's disease. Arch. Med. Sci. 10 (2014), 1235–1238.